Cargando…

Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients

Cancer stem cells (CSCs) are accountable for the progress of head and neck squamous cell carcinoma (HNSCC). This exploratory study evaluated the expression of molecular CSC markers in different tissues of HNSCC patients. Tissue specimens of primary tumor, lymph node metastases and macroscopically he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharaf, Kariem, Lechner, Axel, Haider, Stefan P., Wiebringhaus, Robert, Walz, Christoph, Kranz, Gisela, Canis, Martin, Haubner, Frank, Gires, Olivier, Baumeister, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293237/ https://www.ncbi.nlm.nih.gov/pubmed/34287293 http://dx.doi.org/10.3390/curroncol28040241

Ejemplares similares

Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC
por: Jakob, Mark, et al.
Publicado: (2020)

Human Adipose-Derived Stem/Stromal Cells Promote Proliferation and Migration in Head and Neck Cancer Cells
por: Sharaf, Kariem, et al.
Publicado: (2021)

Isolation and characterization of head and neck cancer-derived peritumoral and cancer-associated fibroblasts
por: Zhou, Jiefu, et al.
Publicado: (2022)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
por: Baumeister, Philipp, et al.
Publicado: (2021)

Künstliche Intelligenz in der Hals-Nasen-Ohren-Heilkunde
por: Haider, Stefan P., et al.
Publicado: (2021)

SLUG‐related partial epithelial‐to‐mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival
por: Schinke, Henrik, et al.
Publicado: (2021)

Primary injection laryngoplasty after chordectomy for small glottic carcinomas
por: Felicio-Briegel, Axelle, et al.
Publicado: (2022)

Association of ALDH1 with Response to Radiotherapy and Its Impact on Survival in Patients with Advanced Stage of Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Dubey, Parul, et al.
Publicado: (2022)

The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer
por: Huang, Hsin-Hui, et al.
Publicado: (2018)

5ʹ-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells
por: Shi, Enxian, et al.
Publicado: (2023)

EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
por: Pan, Min, et al.
Publicado: (2018)

Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma
por: Rao, Roopa S., et al.
Publicado: (2020)

ToSkORL: Selbst- und Fremdeinschätzung bei der Untersuchung des Kopf-Hals-Bereichs
por: Sharaf, Kariem, et al.
Publicado: (2021)

Betahistine Exerts a Dose-Dependent Effect on Cochlear Stria Vascularis Blood Flow in Guinea Pigs In Vivo
por: Ihler, Fritz, et al.
Publicado: (2012)

BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma
por: Koren, Ana, et al.
Publicado: (2016)

Misjudgment of Skills in Clinical Examination Increases in Medical Students Due to a Shift to Exclusively Online Studies during the COVID-19 Pandemic
por: Lechner, Axel, et al.
Publicado: (2022)

Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells
por: Yu, Cheng-Chia, et al.
Publicado: (2011)

A Retrospective Review of the Prognostic Value of ALDH-1, Bmi-1 and Nanog Stem Cell Markers in Esophageal Squamous Cell Carcinoma
por: Hwang, Cheng-Cheng, et al.
Publicado: (2014)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases
por: Senel, Fatma, et al.
Publicado: (2017)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: Pathologist assessment compared to quantitative image analysis
por: Yaghjyan, Lusine, et al.
Publicado: (2022)

The expression of ALDH1 in cervical carcinoma
por: Yao, Tingting, et al.
Publicado: (2011)

ALDH1A3 in CSCs
por: Sullivan, Kelly E., et al.
Publicado: (2017)

Global Deletion of ALDH1A1 and ALDH1A2 Genes Does Not Affect Viability but Blocks Spermatogenesis
por: Topping, Traci, et al.
Publicado: (2022)

Molecular biomarkers NOTCH1, CD44, BMI1, and TP53 in oral squamous cell carcinoma
por: Reshma, Mohammad, et al.
Publicado: (2023)

Immunoexpression of Bmi-1, CK15, Bcl-2 in different types of basal cell carcinomas
por: Iljin, Aleksandra, et al.
Publicado: (2022)

ALDH1 Bio-activates Nifuroxazide to Eradicate ALDH(High) Melanoma-Initiating Cells
por: Sarvi, Sana, et al.
Publicado: (2018)

Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma
por: Rabinovich, Iris, et al.
Publicado: (2018)

Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas
por: Schinke, Henrik, et al.
Publicado: (2020)

A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer
por: Schinke, Henrik, et al.
Publicado: (2022)

ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC
por: Kamarajan, Pachiyappan, et al.
Publicado: (2013)

Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer
por: Kong, Yanan, et al.
Publicado: (2018)

EVI1 as a Marker for Lymph Node Metastasis in HNSCC
por: Idel, Christian, et al.
Publicado: (2020)

ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines
por: Ayoub, C, et al.
Publicado: (2010)

Aldehyde dehydrogenase 1 (ALDH1) immunostaining in axillary lymph node metastases is an independent prognostic factor in ALDH1-positive breast cancer
por: Guan, Xin, et al.
Publicado: (2021)

Linking ALDH1 and retinoic acid signaling
por: Markham, Nicholas O., et al.
Publicado: (2019)

Structure of putative tumor suppressor ALDH1L1
por: Tsybovsky, Yaroslav, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9u7qagj6ahamm74rbbn8kosu6c